Vertex Pharmaceuticals Inc (VRTX)
408.18
+2.91
(+0.72%)
USD |
NASDAQ |
Dec 24, 16:00
407.00
-1.18
(-0.29%)
After-Hours: 05:51
Vertex Pharmaceuticals Research and Development Expense (Annual): 3.69B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly and Co | 9.313B |
| Gilead Sciences Inc | 5.718B |
| Bristol-Myers Squibb Co | 9.299B |
| Pfizer Inc | 10.68B |
| PTC Therapeutics Inc | 666.56M |